Andrew Nickinson

Mr. Andrew Nickinson

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2019 in Annals of Surgery
Verified
Journal Article
Closed access
JHJohn S. M. Houghton
John S. M. Houghton
ANAndrew Nickinson
Andrew Nickinson
AMAlastair J. Morton
Alastair J. Morton
SNSarah Nduwayo
Sarah Nduwayo
CPCoral Jayne Pepper
Coral Jayne Pepper
RSRob D. Sayers
Rob D. Sayers
Objective: To describe and critique tools used to assess frailty in vascular surgery patients, and investigate its associations with patient factors and outcomes. Background: Increasing evidence shows negative impacts of frailty on outcomes in surgical patients, but little investigation of its associations with patient factors has been undertaken. Methods: Systematic review and meta-analysis of studies reporting frailty in vascular surgery patients (PROSPERO registration: CRD42018116253) searching Medline, Embase, CINAHL, PsycINFO, and Scopus. Quality of studies was assessed using Newcastle–Ottawa scores (NOS) and quality of evidence using Grading of Recommendations Assessment, Development, and Evaluation criteria. Associations of frailty with patient factors were investigated by difference in means (MD) or expressed as risk ratios (RRs), and associations with outcomes expressed as odds ratios (ORs) or hazard ratios (HRs). Data were pooled using random-effects models. Results: Fifty-three studies were included in the review and only 8 (15%) were both good quality (NOS ≥ 7) and used a well-validated frailty measure. Eighteen studies (62,976 patients) provided data for the meta-analysis. Frailty was associated with increased age [MD 4.05 years; 95% confidence interval (CI) 3.35, 4.75], female sex (RR 1.32; 95% CI 1.14, 1.54), and lower body mass index (MD −1.81; 95% CI −2.94, −0.68). Frailty was associated with 30-day mortality [adjusted OR (AOR) 2.77; 95% CI 2.01–3.81), postoperative complications (AOR 2.16; 95% CI 1.55, 3.02), and long-term mortality (HR 1.85; 95% CI 1.31, 2.62). Sarcopenia was not associated with any outcomes. Conclusion: Frailty, but not sarcopenia, is associated with worse outcomes in vascular surgery patients. Well-validated frailty assessment tools should be preferred clinically, and in future research.

1 February 2020 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
ANAndrew Nickinson
Andrew Nickinson
BBBernadeta Bridgwood
Bernadeta Bridgwood
JHJohn S.M. Houghton
John S.M. Houghton
SNSarah Nduwayo
Sarah Nduwayo
CPCoral Jayne Pepper
Coral Jayne Pepper
RSRob D. Sayers
Rob D. Sayers

30 January 2020 in Vascular Medicine
Verified
Journal Article
Closed access
PDF file
BBBernadeta M Bridgwood
Bernadeta M Bridgwood
ANAndrew Nickinson
Andrew Nickinson
JHJohn Sm Houghton
John Sm Houghton
CPCoral Jayne Pepper
Coral Jayne Pepper
RSRob D Sayers
Rob D Sayers
This systematic review evaluated the knowledge and awareness of peripheral artery disease (PAD) within the general public (including patients with peripheral vascular disease), nonspecialist healthcare professionals (nsHCP), and trainees (medical students and trainee doctors). Relevant articles were identified from electronic databases using key search terms: ‘peripheral artery disease’; ‘limb ischaemia’; ‘intermittent claudication’; ‘knowledge’; ‘understanding’; ‘public’; ‘medical professional’. The heterogeneous results were described narratively. A lack of knowledge and understanding of PAD (disease awareness) were identified in all groups. Among nsHCPs, factors which affect knowledge include the level of training, early clinical exposure and the presence of family members with cardiovascular/vascular disease. Within the general public, knowledge and awareness was improved if a family member/friend had a diagnosis, or following a patient-centred consultation with any HCP. Public campaigns are proven effective in improving disease knowledge/awareness in conditions such as stroke alongside sustained patient education. These may provide future avenues to improve PAD knowledge and awareness, in order to effectively manage risk factors and minimise delayed or missed diagnosis of PAD. (PROSPERO registration number: CRD42018117304)

1 October 2021 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
JHJohn Sm Houghton
John Sm Houghton
ANAndrew Nickinson
Andrew Nickinson
JHJessica R Helm
Jessica R Helm
JDJivka Dimitrova
Jivka Dimitrova
SDSvetlana Dubkova
Svetlana Dubkova
RSRob D Sayers
Rob D Sayers

1 April 2021 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
ANAndrew Nickinson
Andrew Nickinson
JDJivka Dimitrova
Jivka Dimitrova
JHJohn S.M. Houghton
John S.M. Houghton
LRLauren Rate
Lauren Rate
SDSvetlana Dubkova
Svetlana Dubkova
RDRobert S.M. Davies
Robert S.M. Davies

6 October 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
AMAnna Meffen
Anna Meffen
JHJohn S M Houghton
John S M Houghton
ANAndrew Nickinson
Andrew Nickinson
CPCoral Jayne Pepper
Coral Jayne Pepper
RSRobert D Sayers
Robert D Sayers
LGLaura J Gray
Laura J Gray
Objective Estimate the prevalence/incidence/number of major lower extremity amputations (MLEAs) in the UK; identify sources of routinely collected electronic health data used; assess time trends and regional variation; and identify reasons for variation in reported incidence/prevalence of MLEA. Design Systematic review and narrative synthesis. Data sources Medline, Embase, EMcare, CINAHL, The Cochrane Library, AMED, Scopus and grey literature sources searched from 1 January 2009 to 1 August 2021. Eligibility criteria for selecting studies Reports that provided population-based statistics, used routinely collected electronic health data, gave a measure of MLEA in adults in the general population or those with diabetes in the UK or constituent countries were included. Data extraction and synthesis Data extraction and quality assessment using the Joanna Briggs Institute Critical Appraisal Instruments were performed by two reviewers independently. Due to considerable differences in study populations and methodology, data pooling was not possible; data were tabulated and narratively synthesised, and study differences were discussed. Results Twenty-seven reports were included. Incidence proportion for the general population ranged from 8.2 to 51.1 per 100 000 and from 70 to 291 per 100 000 for the population with diabetes. Evidence for trends over time was mixed, but there was no evidence of increasing incidence. Reports consistently found regional variation in England with incidence higher in the north. No studies reported prevalence. Differences in database use, MLEA definition, calculation methods and multiple procedure inclusion which, together with identified inaccuracies, may account for the variation in incidence. Conclusions UK incidence and trends in MLEA remain unclear; estimates vary widely due to differences in methodology and inaccuracies. Reasons for regional variation also remain unexplained and prevalence uninvestigated. International consensus on the definition of MLEA and medical code list is needed. Future research should recommend standards for the reporting of such outcomes and investigate further the potential to use primary care data in MLEA epidemiology. Systematic review registration PROSPERO CRD42020165592.